Effect of Neurophysiological Facilitation of Respiration on Blood Gases and Hospital Stay in Children With Pneumonia

NCT ID: NCT07070271

Last Updated: 2025-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-01

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate the effect of respiratory neurophysiological facilitation techniques on arterial blood gases, the severity of respiratory illness and duration of hospital stay in hospitalized children with pneumonia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Children who were hospitalized with a clinically and radiologically confirmed diagnosis of pneumonia will participate in this study. Selected Patients will be randomly assigned into two groups of equal number.

One group will only receive conventional chest physical therapy program in form of (postural drainage, chest percussion, vibration and suction if needed). The other group will receive conventional chest physical therapy program along with respiratory neurophysiological facilitation techniques in form of (anterior basal lift, intercostal stretch, abdominal co-contraction).

All patients will receive the treatment program once a day for successive 5 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional chest physical therapy

Children in this group will only receive conventional chest physical therapy program in form of (postural drainage, chest percussion, vibration and suction if needed).

Group Type ACTIVE_COMPARATOR

conventional chest physical therapy

Intervention Type OTHER

conventional chest physical therapy program in form of (postural drainage, chest percussion, vibration and suction if needed) once a day for 5 days.

Conventional chest physical therapy + Neurophysiological facilitation techniques

Children in this group will receive conventional chest physical therapy program along with respiratory neurophysiological facilitation techniques in form of (anterior basal lift, intercostal stretch, abdominal co-contraction).

Group Type EXPERIMENTAL

Respiratory neurophysiological facilitation techniques

Intervention Type OTHER

The respiratory neurophysiological facilitation techniques in form of (anterior basal lift, intercostal stretch, abdominal co-contraction) once a day for 5 days.

conventional chest physical therapy

Intervention Type OTHER

conventional chest physical therapy program in form of (postural drainage, chest percussion, vibration and suction if needed) once a day for 5 days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Respiratory neurophysiological facilitation techniques

The respiratory neurophysiological facilitation techniques in form of (anterior basal lift, intercostal stretch, abdominal co-contraction) once a day for 5 days.

Intervention Type OTHER

conventional chest physical therapy

conventional chest physical therapy program in form of (postural drainage, chest percussion, vibration and suction if needed) once a day for 5 days.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children of both sexes, with age ranged from 6 months to 2 years old.
* All children diagnosed with pneumonia.
* All children should be vitally stable during the study period.

Exclusion Criteria

* Medically unstable children.
* Children with uncontrolled convulsions.
* Children with Osteopenia.
Minimum Eligible Age

6 Months

Maximum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asmaa Ahmed Abd El-samad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asmaa Ahmed Abd El-samad

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Asmaa Ahmed Abd El-samad, master's degree

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo university specialized pediatric hospital (Abo-El Reesh)

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Asmaa Ahmed Abd El-samad, master's degree

Role: CONTACT

+201143185254 ext. +201157896818

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Asmaa Ahmed Abd El-samad, master's degree

Role: primary

+201143185254 ext. +201157896818

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005586

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.